CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation

计划入组 9 人 · 首次发布于 2024 年 6 月 20 日

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

计划入组 3 人 · 首次发布于 2020 年 9 月 23 日

A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL

计划入组 2 人 · 首次发布于 2025 年 9 月 12 日

CRISPR/Cas9-gene therapy (cancer)

DMPK CRISPR/Cas9-gene therapy (Genethon)

CRISPR/Cas9 gene therapy (AAV, Friedreich ataxia)

CELL AND GENE THERAPY CATAPULT

United Kingdom

CRISPR Therapeutics

United States

CRISPR Therapeutics, Inc.

United States

Rambam Hospital Pioneers CRISPR Gene Therapy Trial for Cardiac Amyloidosis

Vertex Pharmaceuticals Partners with Enlaza Therapeutics in $45 Million Deal to Develop Autoimmune and Gene-Editing Therapies

Sidra Medicine Becomes First Hospital in Qatar to Offer CRISPR Gene Therapy for Sickle Cell Disease and Thalassemia